Study links GLP-1 drugs, metformin to lower risk of certain cancers (NYSE:NVO)
2024-07-05
A new study has linked the use of GLP-1 drugs and metformin to a lower risk of developing certain obesity-related cancers in patients with Type 2 diabetes. The study, which was published Friday on the JAMA Network Open website, showed that patients taking GLP-1 drugs or metformin showed a significantlyContinue Reading